Tirzepatide (Mounjaro) for the Treatment of Type 2 Diabetes Mellitus

Am Fam Physician. 2023 Jul;108(1):93-94.

Author

Catherine B Rebitch¹

Affiliation

¹ University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania.

PMID: 37440749

No abstract available

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Gastric Inhibitory Polypeptide
Glucagon-Like Peptide-1 Receptor
Humans
Hypoglycemic Agents / therapeutic use

Substances

tirzepatide
Gastric Inhibitory Polypeptide
Hypoglycemic Agents
Glucagon-Like Peptide-1 Receptor